Gilead Sciences

Stocks could face an inflection point next week as the Federal Reserve meets and Apple posts earnings

Stocks could face an inflection point next week as the Federal Reserve meets and Apple posts earnings

The January market rally faces a major test in the coming week from multiple key events, the most important of which might be the Fed’s rate announcement and press conference. The Fed’s meeting on Tuesday and Wednesday comes amid a flood of corporate earnings reports, with 20% of the S&P 500 reported that week. The …

Stocks could face an inflection point next week as the Federal Reserve meets and Apple posts earnings Read More »

Stocking up on biotech stocks is going to mean a big year for deals.  Who can benefit.

Stocking up on biotech stocks is going to mean a big year for deals. Who can benefit.

Nearly two years after biotech stocks began to crash, small- and mid-cap executives in the space finally accept that stock prices aren’t going down anytime soon. As reality sets in, it’s become a buyer’s market for companies looking for acquisitions and partnerships, according to several pharma and medical technology executives gathered this year. JPMorgan Healthcare …

Stocking up on biotech stocks is going to mean a big year for deals. Who can benefit. Read More »